In the Journal of Asthma 2010; 47: 1106-1115 for the article “Long-term safety of mometasone furoate/formoterol combination for treatment of patients with persistent asthma,” the authors have noticed an error since publication. In the section Plasma Cortisol AUC0–24 h, the sentence that begins “Compared with the baseline values...” should indicate that the nonsignificant reduction refers to MF/F 200/10 rather than FP/S 250/50 in order to coincide with the data presented in the figure. The sentence should read as follows:
“Compared with the baseline values, there were sustained statistically significant reductions in plasma cortisol AUC0–24 h in all treatment groups (p ≤ .043) at weeks 26 and 52, with the exception of a nonsignificant reduction for MF/F 200/10 µg at week 52 (p = .076).”
The authors apologize for this error.